Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study-Reference-Cited by-同舟云学术

Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study

Published:2023-04-03 Issue:7 Volume:58 Page:769-776
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Baranwal Anmol,Chhetri Rakchha,Yeung David,Clark Matthew,Shah Syed^ORCID,Litzow Mark R.^ORCID,Hogan William J.^ORCID,Mangaonkar Abhishek^ORCID,Alkhateeb Hassan B.,Singhal Deepak,Cibich Alia,Bardy Peter,Kok Chung H.^ORCID,Hiwase Devendra K.^ORCID,Shah Mithun Vinod^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-01970-0.pdf

Reference38 articles.

1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

2. Granfeldt Østgård LS, Medeiros BC, Sengeløv H, Nørgaard M, Andersen MK, Dufva IH, et al. Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study. J Clin Oncol. 2015;33:3641–9.

3. Metheny L, Callander NS, Hall AC, Zhang MJ, Bo-Subait K, Wang HL, et al. Allogeneic transplantation to treat therapy-related myelodysplastic syndrome and acute myelogenous leukemia in adults. Transpl Cell Ther. 2021;27:923.e1–923.e12.

4. McNerney ME, Godley LA, le Beau MM. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 2017;17:513–27.

5. Baranwal A, Hahn CN, Shah MV, Hiwase DK. Role of germline predisposition to therapy-related myeloid neoplasms. Curr Hematol Malig Rep. 2022;17:254–65.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms;Journal of Bone Oncology;2024-08

2. Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis;Annals of Hematology;2024-07-19

3. Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms;Blood Advances;2024-02-13

4. Special Issue “Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms”;International Journal of Molecular Sciences;2024-02-08

5. Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms;Haematologica;2024-02-01